Cumberland Pharmaceutical... (CPIX)
NASDAQ: CPIX
· Real-Time Price · USD
4.97
-0.06 (-1.19%)
At close: May 30, 2025, 3:59 PM
4.80
-3.42%
After-hours: May 30, 2025, 04:26 PM EDT
-1.19% (1D)
| Bid | 4.79 |
| Market Cap | 74.36M |
| Revenue (ttm) | 41.08M |
| Net Income (ttm) | -3.28M |
| EPS (ttm) | -0.24 |
| PE Ratio (ttm) | -20.71 |
| Forward PE | -9.22 |
| Analyst | n/a |
| Ask | 5.19 |
| Volume | 21,482 |
| Avg. Volume (20D) | 71,524 |
| Open | 5.02 |
| Previous Close | 5.03 |
| Day's Range | 4.80 - 5.21 |
| 52-Week Range | 1.04 - 7.25 |
| Beta | -0.35 |
About CPIX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CPIX
Website n/a
3 days ago
+9.36%
Cumberland Pharmaceuticals shares are trading high...
Unlock content with
Pro Subscription
3 weeks ago
-1.34%
Cumberland Pharmaceuticals shares are trading higher after the company reported a year-over-year increase in Q1 financial results.
3 weeks ago · seekingalpha.com
Cumberland Pharmaceuticals, Inc. (CPIX) Q1 2025 Earnings Call TranscriptCumberland Pharmaceuticals, Inc. (NASDAQ:CPIX ) Q1 2025 Earnings Conference Call May 6, 2024 4:30 PM ET Company Participants Molly Aggas - Account Supervisor, Dalton Agency A.J. Kazimi - CEO Todd Anth...
2 months ago · seekingalpha.com
Cumberland Pharmaceuticals Inc. (CPIX) Q4 2024 Earnings Call TranscriptCumberland Pharmaceuticals Inc. (NASDAQ:CPIX ) Q4 2024 Earnings Conference Call March 4, 2025 4:30 PM ET Company Participants Molly Aggas – Account Supervisor-Dalton Agency A.J. Kazimi – Chief Executi...